Diong Sui 의 보수는 LYC Healthcare Berhad 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	-RM 20m
Dec 31 2023	n/a	n/a	-RM 17m
Sep 30 2023	n/a	n/a	-RM 17m
Jun 30 2023	n/a	n/a	-RM 17m
Mar 31 2023	RM 1m	RM 660k	-RM 19m
Dec 31 2022	n/a	n/a	-RM 12m
Sep 30 2022	n/a	n/a	-RM 12m
Jun 30 2022	n/a	n/a	-RM 11m
Mar 31 2022	RM 837k	RM 530k	-RM 9m
Dec 31 2021	n/a	n/a	-RM 11m
Sep 30 2021	n/a	n/a	-RM 12m
Jun 30 2021	n/a	n/a	-RM 12m
Mar 31 2021	RM 779k	RM 443k	-RM 12m
Dec 31 2020	n/a	n/a	-RM 14m
Sep 30 2020	n/a	n/a	-RM 12m
Jun 30 2020	n/a	n/a	-RM 11m
Mar 31 2020	RM 484k	RM 324k	-RM 10m
Dec 31 2019	n/a	n/a	-RM 8m
Sep 30 2019	n/a	n/a	-RM 8m
Jun 30 2019	n/a	n/a	-RM 8m
Mar 31 2019	RM 429k	RM 300k	-RM 8m
Dec 31 2018	n/a	n/a	-RM 7m
Sep 30 2018	n/a	n/a	-RM 6m
Jun 30 2018	n/a	n/a	-RM 4m
Mar 31 2018	RM 287k	RM 287k	-RM 3m

보상 대 시장: Diong 의 총 보상 ($USD 216.52K )은 MY 시장( $USD 105.45K ).

보상과 수익: 회사가 수익성이 없는 동안 Diong 의 보상이 증가했습니다.

CEO

Diong Sui (69 yo)

6.8yrs

테뉴어

RM 1,019,229

보상

Mr. Diong Hoe Sui has been an Executive Director of LYC Healthcare Berhad (formerly known as Mexter Technology Berhad) since July 12, 2016. Mr. Sui served as Managing Director of Ralco Corporation Berhad (...

리더십 팀

이름	위치	테뉴어	보상	소유권
Diong Sui	MD, Group CEO & Executive Director	6.8yrs	RM 1.02m	데이터 없음
Sook Chong	Chief Financial Officer	less than a year	데이터 없음	데이터 없음
Lai Chow	Senior Group Accountant	1.6yrs	데이터 없음	데이터 없음
Siew Chong	Head of the ICT & Electronics Engineering Division	no data	데이터 없음	데이터 없음
Hoo Soh	Chief Executive Officer of Project Management Division	no data	데이터 없음	데이터 없음
Yan Lim	Chief Operating Officer of Confinement Centres	3.3yrs	데이터 없음	데이터 없음
Ai Tan	Company Secretary	no data	데이터 없음	데이터 없음
Yuen Tai	Company Secretary	no data	데이터 없음	데이터 없음

2.4yrs

평균 재임 기간

55.5yo

평균 연령

경험이 풍부한 관리: LYC 의 관리팀은 경험 ( 2.4 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Diong Sui	MD, Group CEO & Executive Director	7.9yrs	RM 1.02m	데이터 없음
Mohd bin Ahmad	Independent Non Executive Director	7.6yrs	RM 63.30k	데이터 없음
Abdul bin Mohamad Zabidi	Independent Non-Executive Chairman	3.3yrs	RM 93.40k	데이터 없음
Muraly Daran	Independent Non-Executive Director	3.8yrs	RM 64.55k	데이터 없음
Zuan Poh	Independent & Non Executive Director	1.1yrs	데이터 없음	데이터 없음

3.8yrs

평균 재임 기간

65yo

평균 연령

경험이 풍부한 이사회: LYC 의 이사회는 경험(평균 재직 기간 3.8 년)으로 간주됩니다.

LYC Healthcare Berhad 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Lyc Healthcare Berhad Appoints Chong Sook Peng as Chief Financial Officer

LYC Healthcare Berhad Announces Resignation of Mr. Cheah SEK Hon as Chief Financial Officer , Effective from 28 April 2024

LYC Healthcare Berhad Announces Resignation of Encik Ahmad Rafique Bin Mat Tahir as Chief Operating Officer, Effective 19 February.2024

LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation Is Looking A Bit Stretched At The Moment

LYC Healthcare Berhad, Annual General Meeting, Sep 21, 2023

LYC Healthcare Berhad Appoints Poh Zuan Yin as Independent and Non Executive Member of Audit Committee

Recent updates

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2024 earnings released: RM0.03 loss per share (vs RM0.035 loss in FY 2023)

New minor risk - Share price stability

LYC Healthcare Berhad (KLSE:LYC) Doing What It Can To Lift Shares

Lyc Healthcare Berhad Appoints Chong Sook Peng as Chief Financial Officer

Third quarter 2024 earnings released: RM0.006 loss per share (vs RM0.007 loss in 3Q 2023)

LYC Healthcare Berhad Announces Resignation of Mr. Cheah SEK Hon as Chief Financial Officer , Effective from 28 April 2024

LYC Healthcare Berhad Announces Resignation of Encik Ahmad Rafique Bin Mat Tahir as Chief Operating Officer, Effective 19 February.2024

Second quarter 2024 earnings released: RM0.006 loss per share (vs RM0.009 loss in 2Q 2023)

LYC Healthcare Berhad has filed a Follow-on Equity Offering in the amount of MYR 12.804571 million.

New minor risk - Share price stability

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation Is Looking A Bit Stretched At The Moment

Full year 2023 earnings released: RM0.035 loss per share (vs RM0.021 loss in FY 2022)

LYC Healthcare Berhad, Annual General Meeting, Sep 21, 2023

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2023 earnings released: RM0.035 loss per share (vs RM0.021 loss in FY 2022)

LYC Healthcare Berhad Appoints Poh Zuan Yin as Independent and Non Executive Member of Audit Committee

LYC Healthcare Berhad (KLSE:LYC) acquired 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei.

Is LYC Healthcare Berhad (KLSE:LYC) A Risky Investment?

Third quarter 2023 earnings released: RM0.007 loss per share (vs RM0.007 loss in 3Q 2022)

LYC Healthcare Berhad's (KLSE:LYC) Returns On Capital Are Heading Higher

Second quarter 2023 earnings released: RM0.009 loss per share (vs RM0.007 loss in 2Q 2022)

It's Unlikely That The CEO Of LYC Healthcare Berhad (KLSE:LYC) Will See A Huge Pay Rise This Year

Here's Why LYC Healthcare Berhad (KLSE:LYC) Is Weighed Down By Its Debt Load

LYC Healthcare Berhad announced a financing transaction

Full year 2022 earnings released: RM0.021 loss per share (vs RM0.033 loss in FY 2021)

LYC Healthcare Berhad, Annual General Meeting, Sep 22, 2022

LYC Healthcare Berhad (KLSE:LYC) entered into a conditional share sale agreement to acquire a 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei for MYR 5.5 million.

LYC Healthcare Berhad (KLSE:LYC) entered into a conditional share sale agreement to acquire a 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei for MYR 5.5 million.

LYC Healthcare Berhad Announces Appointment of Mr. Cheah SEK Hon as Chief Financial Officer

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investors Will Want LYC Healthcare Berhad's (KLSE:LYC) Growth In ROCE To Persist

LYC Healthcare Berhad (KLSE:LYC) agreed to acquire Tao Global Ventures Sdn Bhd from Dinesh A/L Kanasen and Sarahanna A/P Selvarajah for RMB 4 million.

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2021 earnings released: RM0.033 loss per share (vs RM0.029 loss in FY 2020)

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2021 earnings released: RM0.032 loss per share (vs RM0.029 loss in FY 2020)

How Should Investors React To LYC Healthcare Berhad's (KLSE:LYC) CEO Pay?

Third quarter 2021 earnings released: RM0.013 loss per share (vs RM0.006 loss in 3Q 2020)

Non-Independent Non-Executive Director has left the company

LYC Healthcare Berhad Announces Resignation of Josephie Sui Sze Pin as Non Independent and Non Executive Member of Remuneration Committee

New 90-day low: RM0.25

New 90-day low: RM0.29

New 90-day low: RM0.30

New 90-day low: RM0.32

Second quarter 2021 earnings released: RM0.008 loss per share

LYC Healthcare Berhad (KLSE:LYC) acquired remaining 49% stake in LYC Cosmetic & Aesthetic Sdn Bhd from Xing Dao International Pte. Ltd for MYR 0.05 million.

New 90-day low: RM0.33

First quarter earnings released

First quarter earnings released

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령